We are live on ! Find out more
RCP

Rho Capital Partners Portfolio holdings

AUM $20.4M
This Fund
S&P 500
This Quarter Est. Return
-22.05%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$120M
AUM Growth
-$34.3M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 91.95%
2 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$59.9M 49.9%
3,766,666
TVRD
2
Tvardi Therapeutics
TVRD
$30M
$35.6M 29.66%
77,752
MRSN
3
DELISTED
Mersana Therapeutics
MRSN
$14.8M 12.35%
31,858
LVO icon
4
LiveOne
LVO
$71.7M
$9.66M 8.05%
372,414
SENS icon
5
Senseonics Holdings Inc
SENS
$267M
$62K 0.05%
7,980

Similar funds

Rho Capital Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Rho Capital Partners held 5 positions worth $120M, down 22% from $154M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2020: portfolio turnover was 0%. Rho Capital Partners opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 91% a quarter earlier, followed by Communication Services.

  • Rho Capital Partners's ten largest holdings make up 100% of its $120M portfolio in Q3 2020.
  • Rho Capital Partners opened 0 new positions and closed 0 in Q3 2020.
  • Rho Capital Partners's portfolio value fell 22% quarter-over-quarter to $120M.

Based on Rho Capital Partners's 13F filing for Q3 2020, filed 23 Nov 2020.